Volume | 510,097 |
|
|||||
News | - | ||||||
Day High | 0.84 | Low High |
|||||
Day Low | 0.7896 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Assertio Holdings Inc | ASRT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.79 | 0.7896 | 0.84 | 0.7851 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,189 | 510,097 | $ 0.8188772 | $ 417,707 | - | 0.7324 - 8.01 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:58:07 | 100 | $ 0.8201 | USD |
Assertio Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
79.8M | 95.00M | - | 152.07M | -331.94M | -3.49 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Assertio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ASRT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.754 | 0.94 | 0.7324 | 0.8237747 | 1,287,993 | 0.0661 | 8.77% |
1 Month | 0.97 | 0.974899 | 0.7324 | 0.8495577 | 798,194 | -0.1499 | -15.45% |
3 Months | 0.83 | 1.21 | 0.7324 | 0.9331624 | 973,726 | -0.0099 | -1.19% |
6 Months | 2.16 | 2.37 | 0.7324 | 1.10 | 1,248,344 | -1.34 | -62.03% |
1 Year | 5.37 | 8.01 | 0.7324 | 3.25 | 1,629,462 | -4.55 | -84.73% |
3 Years | 0.56 | 8.01 | 0.419 | 2.98 | 1,433,282 | 0.2601 | 46.45% |
5 Years | 4.14 | 8.01 | 0.33 | 1.70 | 2,331,602 | -3.32 | -80.19% |
Assertio Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain. |